ReviewClinical ophthalmology (Auckland, N.Z.)2026
Premium Intraocular Lenses and Their Impact on Visual Field Assessment: A Narrative Review.
Review in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Premium intraocular lens (IOL) such as enhanced monofocal, extended depth-of-focus (EDOF) and multifocal IOL has become increasing popular due to its ability to treat pseudophakic presbyopia and it also offers a spectacle-free lifestyle. However, the difference in light focality between these types of lenses may affect post operative outcomes, such as the worsening of visual field defects. From the existing literature, seven articles were selected for inclusion in this review to determine the effect of these presbyopia-correcting lenses on visual field assessment. Inclusion criteria included articles involving healthy individuals without ocular pathologies and patients diagnosed with glaucoma, all whom had undergone cataract surgery, and had a comparison of visual field outcomes between different types of intraocular lenses such as multifocal, EDOF, enhanced monofocal, and standard monofocal. A key limitation in the available evidence is that most of these studies involved healthy individuals without ocular comorbidities. Only two studies recruited patients diagnosed with glaucoma implanted with an enhanced monofocal lens or a standard monofocal lens. There have been no studies on glaucoma patients implanted with either EDOF or multifocal lenses. In conclusion, EDOF and enhanced monofocal may be viable options for patients with glaucoma seeking spectacle independence after cataract surgery. Multifocal and trifocal lenses should be avoided in this group of patients because of their refractive and diffractive aberration effects on the visual field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.